These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 27614685)

  • 1. Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.
    Kumar M; Dhatwalia SK; Dhawan DK
    Tumour Biol; 2016 Nov; 37(11):14341-14354. PubMed ID: 27614685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad targeting of angiogenesis for cancer prevention and therapy.
    Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
    Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.
    Shanmugam MK; Warrier S; Kumar AP; Sethi G; Arfuso F
    Curr Vasc Pharmacol; 2017; 15(6):503-519. PubMed ID: 28707601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.
    Ranieri G; Gasparini G
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):241-53. PubMed ID: 12477290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.
    Gacche RN; Meshram RJ
    Biochim Biophys Acta; 2014 Aug; 1846(1):161-79. PubMed ID: 24836679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Angiogenic Activity of Curcumin in Cancer Therapy: A Narrative Review.
    Shakeri A; Ward N; Panahi Y; Sahebkar A
    Curr Vasc Pharmacol; 2019; 17(3):262-269. PubMed ID: 29424316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.
    Lopes-Coelho F; Martins F; Pereira SA; Serpa J
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis.
    Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
    Biomed Pharmacother; 2023 Jul; 163():114806. PubMed ID: 37163782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis: molecular pathways and therapeutic targets.
    Weis SM; Cheresh DA
    Nat Med; 2011 Nov; 17(11):1359-70. PubMed ID: 22064426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis: new targets for the development of anticancer chemotherapies.
    Gourley M; Williamson JS
    Curr Pharm Des; 2000 Mar; 6(4):417-39. PubMed ID: 10788590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic targets for potential disorders.
    Bhadada SV; Goyal BR; Patel MM
    Fundam Clin Pharmacol; 2011 Feb; 25(1):29-47. PubMed ID: 20199582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of Cancer Biology, Pathophysiological Development and It's Treatment Modalities: Current Challenges of Cancer anti-Angiogenic Therapy.
    Al-Ostoot FH; Salah S; Khanum SA
    Cancer Invest; 2024 Aug; 42(7):559-604. PubMed ID: 38874308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis as a potential target of pharmaconutrients in cancer therapy.
    Granci V; Dupertuis YM; Pichard C
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):417-22. PubMed ID: 20453647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature.
    Petrillo S; Tolosano E; Munaron L; Genova T
    Recent Pat Anticancer Drug Discov; 2018; 13(4):422-427. PubMed ID: 29807523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic properties of artemisinin derivatives (Review).
    Wei T; Liu J
    Int J Mol Med; 2017 Oct; 40(4):972-978. PubMed ID: 28765885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The host support niche as a control point for tumor dormancy: implications for tumor development and beyond.
    Hahnfeldt P
    Adv Exp Med Biol; 2013; 734():19-35. PubMed ID: 23143973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature's Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization.
    Kumari R; Syeda S; Shrivastava A
    Curr Med Chem; 2024; 31(32):5281-5304. PubMed ID: 38425113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.